Surgical Science Sweden AB (publ)
SUSRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $263,641 | $209,157 | $250,691 | $251,549 |
| % Growth | 26% | -16.6% | -0.3% | – |
| Cost of Goods Sold | $93,211 | $72,763 | $78,092 | $81,474 |
| Gross Profit | $170,430 | $136,394 | $172,599 | $170,075 |
| % Margin | 64.6% | 65.2% | 68.8% | 67.6% |
| R&D Expenses | $55,027 | $52,123 | $55,206 | $51,656 |
| G&A Expenses | $20,484 | $23,493 | $43,752 | $22,338 |
| SG&A Expenses | $76,950 | $81,276 | $96,874 | $72,236 |
| Sales & Mktg Exp. | $56,466 | $57,783 | $53,122 | $49,898 |
| Other Operating Expenses | $11,204 | $25,383 | -$3,419 | $7,055 |
| Operating Expenses | $143,181 | $158,782 | $148,661 | $130,947 |
| Operating Income | $27,249 | -$22,388 | $23,938 | $39,128 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |
| Other Income/Exp. Net | $2,899 | $3,670 | $22,273 | $295 |
| Pre-Tax Income | $30,148 | -$18,718 | $46,211 | $39,423 |
| Tax Expense | $9,746 | $1,359 | $12,974 | $3,159 |
| Net Income | $20,402 | -$20,077 | $33,237 | $36,264 |
| % Margin | 7.7% | -9.6% | 13.3% | 14.4% |
| EPS | 0.4 | -0.39 | 0.65 | 0.71 |
| % Growth | 202.6% | -160% | -8.5% | – |
| EPS Diluted | 0.4 | -0.39 | 0.65 | 0.71 |
| Weighted Avg Shares Out | 51,026 | 51,026 | 51,026 | 51,026 |
| Weighted Avg Shares Out Dil | 51,026 | 51,026 | 51,026 | 51,026 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3,670 | $4,000 | $295 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $27,249 | -$22,387 | $23,938 | $39,127 |
| % Margin | 10.3% | -10.7% | 9.5% | 15.6% |